Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 570 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact570 DOIs

Add license metadata to 367 records

License metadata tells indexers and readers how each article may be reused.

High impact367 DOIs

Deposit reference lists for 52 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact52 DOIs

DOIs for this ISSN

Showing the top 5 of 625 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Cardiovascular Disease and Its Implication for Higher Catast… (10.36469/jkheor.2023.70252)	References ORCID License	88.21	14
2	Quality of Life in Wilson’s Disease: A Systematic Literature… (10.36469/jheor.2021.29987)	References ORCID License	83.55	12
3	Evaluation of Vaso-occlusive Crises in United States Sickle… (10.36469/9667)	ORCID License	78.99	37
4	Value-based Reimbursement as a Mechanism to Achieve Social a… (10.36469/jheor.2023.89151)	ORCID License	76.57	33
5	Use of Open Claims vs Closed Claims in Health Outcomes Resea… (10.36469/jheor.2023.87538)	ORCID License	72.36	27
6	High Healthcare Utilization in Adolescents with Sickle Cell… (10.36469/10512)	ORCID License	71.57	26
7	Multiple Comorbidities, Psychiatric Disorders, Healthcare Re… (10.36469/jheor.2022.37307)	References ORCID	70.75	25
8	Relative Importance of Mode of Administration in Treatment P… (10.36469/9817)	ORCID License	69.90	24
9	Cost Savings and Reduced Health Care Utilization Associated… (10.36469/jheor.2020.14529)	ORCID License	69.90	24
10	No Apparent Workup for most new Indeterminate Pulmonary Nodu… (10.36469/9674)	ORCID License	67.12	21
11	Analysis of Healthcare Resource Utilization and Costs after… (10.36469/9791)	ORCID License	67.12	21
12	A Criterion-based Approach for the Systematic and Transparen… (10.36469/9896)	ORCID License	63.94	18
13	Author Correction: Surgical Treatment Patterns, Healthcare R… (10.36469/jheor.2022.33289)	Abstract References ORCID	63.38	6
14	Healthcare Utilization, Costs of Care, and Mortality Among P… (10.36469/63185)	ORCID License	62.76	17
15	The Burden of Hypoxic Respiratory Failure in Preterm and Ter… (10.36469/9682)	ORCID License	61.52	16
16	A Pragmatic Clinical Trial to Compare the Real-World Effecti… (10.36469/9731)	ORCID License	61.52	16
17	How Do Diabetes Models Measure Up? A Review of Diabetes Econ… (10.36469/9831)	ORCID License	61.52	16
18	Treatment Patterns and Outcomes Among Patients With Advanced… (10.36469/jheor.2023.87853)	ORCID License	61.52	16
19	Cost-effectiveness Analysis of Ribociclib plus Letrozole ver… (10.36469/9725)	ORCID License	58.80	14
20	Burden of Comorbidities and Healthcare Resource Utilization… (10.36469/jheor.2022.38847)	ORCID License	57.31	13
21	Mobile Integrated Healthcare: Preliminary Experience and Imp… (10.36469/9819)	ORCID License	55.70	12
22	Effectiveness of Single-Tablet Combination Therapy in Improv… (10.36469/jheor.2024.91396)	ORCID License	55.70	12
23	Clinical and Cost Burden of Primary Sjögren’s Syndrome: Desc… (10.36469/9807)	ORCID License	53.96	11
24	Estimating the Burden of Cost in Chronic Graft-versus-Host D… (10.36469/9814)	ORCID License	53.96	11
25	Cost-effectiveness Analysis of Rivaroxaban versus Acenocouma… (10.36469/9823)	ORCID License	53.96	11
26	Cost-Effectiveness of the CNIC-Polypill Strategy Compared Wi… (10.36469/jheor.2022.39768)	ORCID License	53.96	11
27	Real-World Assessment of Weight Change in African American F… (10.36469/30184)	References ORCID	52.07	10
28	Cost-effectiveness of Simple Insulin Infusion Devices Compar… (10.36469/9789)	ORCID License	52.07	10
29	Using Real World Evidence to Describe Pulmonary Arterial Hyp… (10.36469/9812)	ORCID License	52.07	10
30	High Costs of Dialysis Transportation in the United States:… (10.36469/9861)	ORCID License	52.07	10
31	Cost Impact Model of a Novel Multi-mRNA Host Response Assay… (10.36469/jheor.2020.12637)	ORCID License	52.07	10
32	The Economic and Humanistic Burden of Pediatric-Onset Multip… (10.36469/jheor.2022.37992)	ORCID License	52.07	10
33	Adherence to First-Line Intravesical Bacillus Calmette-Guéri… (10.36469/jheor.2024.124208)	ORCID License	52.07	10
34	Disutility Study for Adult Patients with Moderate to Severe… (10.36469/9685)	ORCID License	50.00	9
35	Retrospective Analysis of Healthcare Resource Use, Treatment… (10.36469/9779)	ORCID License	50.00	9
36	Identifying Priority Areas for Increasing the Supply of Medi… (10.36469/9787)	ORCID License	50.00	9
37	Cost-effectiveness of Triple Therapy with Telaprevir for Chr… (10.36469/9870)	ORCID License	50.00	9
38	mpact of the Timing of Enzyme Replacement Therapy Initiation… (10.36469/jheor.2022.36540)	ORCID License	50.00	9
39	Treatment Patterns of Follicular Lymphoma in the United Stat… (10.36469/jheor.2022.38070)	ORCID License	50.00	9
40	Healthcare Resource Utilization and Costs Among Patients Wit… (10.36469/jheor.2023.68191)	ORCID License	50.00	9
41	Anxiety, Depression, and Stress Reaction/Adjustment Disorder… (10.36469/jheor.2023.70238)	ORCID License	50.00	9
42	Patient Preference for Once-Weekly Dosing in Type 2 Diabetes… (10.36469/9826)	ORCID License	47.71	8
43	Treatment Patterns for Patients on Overactive Bladder Therap… (10.36469/9841)	ORCID License	47.71	8
44	Validity and Reliability Analysis of Knowledge of, Attitude… (10.36469/9891)	ORCID License	47.71	8
45	Long-Acting Injectable Antipsychotic Use in Patients with Sc… (10.36469/jheor.2021.22979)	References ORCID	47.71	8
46	Cost-Effectiveness of Apomorphine Sublingual Film as an "On-… (10.36469/jheor.2021.29488)	References ORCID	47.71	8
47	The Hidden Economic Consequences of Migraine to the UK Gover… (10.36469/jheor.2023.87790)	ORCID License	47.71	8
48	Cost-Effectiveness Analysis of Transanal Irrigation for Mana… (10.36469/9781)	ORCID License	45.15	7
49	Quality of Life with Late-Onset Pompe Disease: Qualitative I… (10.36469/jheor.2023.68157)	ORCID License	45.15	7
50	Economic Impact of Postoperative Urinary Retention in the US… (10.36469/jheor.2024.121641)	ORCID License	45.15	7